Patent · US Active

Method for producing corneal endothelial cell

US9347042B2 · kind B2 · utility

15Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2012
Grant dateMay 24, 2016
Priority date
Expiry dateOct 5, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of efficiently producing corneal endothelial cells, particularly from corneal stroma or iPS cell-derived neural crest stem cells, a method of producing corneal endothelial cells stably in a large amount by inducing more efficient differentiation of stem cells into corneal endothelial cells, and a medicament containing corneal endothelial cells. The method of inducing differentiation of stem cells into corneal endothelial cells includes a step of culturing the stem cells in a differentiation induction medium containing a GSK3 inhibitor (preferably a GSK3β inhibitor) and retinoic acid, with the differentiation induction medium preferably further containing one or more of TGFb2, insulin, a ROCK inhibitor, and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.